RA Capital Management, L.P. 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-14 9:10 pm Sale | 2024-05-10 | 13D | iTeos Therapeutics, Inc. ITOS | RA Capital Management, L.P. | 3,659,046 9.990% | -758,213 (-17.16%) | Filing |
| 2020-08-05 4:30 pm Purchase | 2009-02-28 | 13D | iTeos Therapeutics, Inc. ITOS | RA Capital Management, L.P. | 4,417,259 13.200% | 4,417,259 (New Position) | Filing |